Lee C. Preusser
AbbVie (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Cardiac electrophysiology and arrhythmias, Nitric Oxide and Endothelin Effects, Cardiac Ischemia and Reperfusion, Anesthesia and Sedative Agents
Most-Cited Works
- → Bcl-2 family proteins are essential for platelet survival(2007)422 cited
- → ABT‐089: Pharmacological Properties of a Neuronal Nicotinic Acetylcholine Receptor Agonist for the Potential Treatment of Cognitive Disorders(2004)68 cited
- → Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2consumption in dogs(2007)63 cited
- → Discovery of ((4R,5S)-5-Amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a Highly Potent, Selective, Orally Efficacious, and Safe Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes(2006)52 cited
- → Optimization of Chromone-2-carboxamide Melanin Concentrating Hormone Receptor 1 Antagonists: Assessment of Potency, Efficacy, and Cardiovascular Safety(2006)48 cited
- → Discovery and Characterization of Aminopiperidinecoumarin Melanin Concentrating Hormone Receptor 1 Antagonists(2005)48 cited
- → Hypertension induced by blockade of ETBreceptors in conscious nonhuman primates: role of ETAreceptors(2002)41 cited
- → Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families(2012)30 cited
- → Screening for Cardiovascular Safety: A Structure−Activity Approach for Guiding Lead Selection of Melanin Concentrating Hormone Receptor 1 Antagonists(2006)27 cited
- → Cardiovascular Effects of Torcetrapib in Conscious and Pentobarbital-anesthetized Dogs(2009)15 cited